Status:
NOT_YET_RECRUITING
In Vitro Models From Pediatric Brain Tumors
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Glioma, Malignant
Ependymoma
Eligibility:
All Genders
1-35 years
Brief Summary
Tumors of the Central Nervous System (CNS) represent the leading cause of cancer-related deaths in children. Current treatment options are not curative for most malignant histologies, and intense prec...
Eligibility Criteria
Inclusion
- Children and young adults who undergo standard surgical resection for suspected primary brain tumors or recurrent brain tumors
- signed written informed consent
Exclusion
- no informed consent
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06499636
Start Date
September 1 2024
End Date
June 30 2029
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Oncology Unit- Fondazione Policlinico Gemelli IRCCS
Roma, Rome, Italy, 00168